文献速递眼底病与葡萄膜炎

氟轻松醋酸酯植入剂治疗ATTRV30M患者视网膜淀粉样血管病性黄斑水肿

FLUOCINOLONE ACETONIDE IMPLANT IN THE TREATMENT OF RETINAL ANGIOPATHY MACULAR EDEMA IN ATTRV30M PATIENTS.
PubMed 文献 · Retina · 2025-01-01

这项回顾性观察性病例系列纳入15例(15眼)ATTRV30M患者,评估氟轻松醋酸酯植入剂(0.2微克/天)治疗视网膜淀粉样血管病性黄斑水肿的有效性与安全性。结果显示最佳矫正视力与中心凹厚度较基线在所有时间点均有统计学显著改善,眼压随访期间无统计学显著差异。作者认为该植入剂可带来持续的功能和解剖改善。

要点

  • 15眼ATTRV30M患者接受氟轻松醋酸酯植入剂(0.2微克/天)治疗黄斑水肿。
  • 最佳矫正视力和中心凹厚度在所有随访时间点较基线有统计学显著改善。
  • 随访期间眼压无统计学显著差异。

核心结论

  • 作者认为,视网膜淀粉样血管病所致黄斑水肿患者接受氟轻松醋酸酯植入剂治疗后,较基线显示持续的功能改善和解剖改善。

研究设计与样本

  • 回顾性观察性病例系列,纳入2010年1月至2019年12月期间接受氟轻松醋酸酯植入剂(0.2微克/天)治疗黄斑水肿的ATTRV30M患者眼。

主要发现

  • 共纳入15例ATTRV30M患者的15眼,所有患者均已接受肝移植,所有患者均已接受白内障手术。
  • 87%的眼有Ahmed阀植入,80%的眼因玻璃体淀粉样变性行玻璃体切除术。
  • 最佳矫正视力和中心凹厚度在所有时间点较基线均有统计学显著改善。
  • 随访期间眼压无统计学显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effectiveness and safety of the fluocinolone acetonide implant (0.2 µ g/day fluocinolone acetonide, ILUVIEN) in macular edema due to retinal amyloid angiopathy in patients with hereditary transthyretin amyloidosis associated with the V30M mutation (ATTRV30M). METHODS: Retrospective observational case series of ATTRV30M patients' eyes treated with the implant for macular edema, from January 2010 to December 2019. Best-corrected visual acuity, central foveal thickness, and intraocular pressure were measured at baseline, at 1 week, and at months 1, 3, 6, and 12. RESULTS: Fifteen eyes of 15 ATTRV30M patients with fluocinolone acetonide implants were included. All patients had already received a liver transplant. All had already been submitted to cataract surgery: 87% had an Ahmed valve implant, and 80% were vitrectomized due to vitreous amyloidosis. A statistically significant improvement in best-corrected visual acuity and in central foveal thickness at all time points was found compared with baseline. There was no statistically significant difference in intraocular pressure during the follow-up. CONCLUSION: Patients with macular edema due to retinal amyloid angiopathy treated with the fluocinolone acetonide implant showed sustained increased functional results and anatomical improvement compared with baseline.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Quintas Cales S, Bragança FC, Marques JH, et al. FLUOCINOLONE ACETONIDE IMPLANT IN THE TREATMENT OF RETINAL ANGIOPATHY MACULAR EDEMA IN ATTRV30M PATIENTS. Retina. 2025. PMID: 40456135. doi:10.1097/IAE.0000000000004542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。